Menu
GWAS Study

Common and rare variant analysis in early-onset bipolar disorder vulnerability.

Jamain S, Cichon S, Etain B et al.

25111785 PubMed ID
GWAS Study Type
9749 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

JS
Jamain S
CS
Cichon S
EB
Etain B
MT
Mühleisen TW
GA
Georgi A
ZN
Zidane N
CL
Chevallier L
DJ
Deshommes J
NA
Nicolas A
HA
Henrion A
DF
Degenhardt F
MM
Mattheisen M
PL
Priebe L
MF
Mathieu F
KJ
Kahn JP
HC
Henry C
BA
Boland A
ZD
Zelenika D
GI
Gut I
HS
Heath S
LM
Lathrop M
MW
Maier W
AM
Albus M
RM
Rietschel M
ST
Schulze TG
MF
McMahon FJ
KJ
Kelsoe JR
HM
Hamshere M
CN
Craddock N
NM
Nöthen MM
BF
Bellivier F
LM
Leboyer M
Chapter II

Abstract

Summary of the research findings

Bipolar disorder is one of the most common and devastating psychiatric disorders whose mechanisms remain largely unknown. Despite a strong genetic contribution demonstrated by twin and adoption studies, a polygenic background influences this multifactorial and heterogeneous psychiatric disorder. To identify susceptibility genes on a severe and more familial sub-form of the disease, we conducted a genome-wide association study focused on 211 patients of French origin with an early age at onset and 1,719 controls, and then replicated our data on a German sample of 159 patients with early-onset bipolar disorder and 998 controls. Replication study and subsequent meta-analysis revealed two genes encoding proteins involved in phosphoinositide signalling pathway (PLEKHA5 and PLCXD3). We performed additional replication studies in two datasets from the WTCCC (764 patients and 2,938 controls) and the GAIN-TGen cohorts (1,524 patients and 1,436 controls) and found nominal P-values both in the PLCXD3 and PLEKHA5 loci with the WTCCC sample. In addition, we identified in the French cohort one affected individual with a deletion at the PLCXD3 locus and another one carrying a missense variation in PLCXD3 (p.R93H), both supporting a role of the phosphatidylinositol pathway in early-onset bipolar disorder vulnerability. Although the current nominally significant findings should be interpreted with caution and need replication in independent cohorts, this study supports the strategy to combine genetic approaches to determine the molecular mechanisms underlying bipolar disorder.

211 European ancestry cases, 1,719 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

9749
Total Participants
GWAS
Study Type
Yes
Replicated
159 European ancestry cases, 998 European ancestry controls, 2,288 cases, 4,374 controls
Replication Participants
European
Ancestry
France, U.S., U.K., Germany
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.